[ET Net News Agency, 25 August 2026] EVEREST MED (01952) rose 10.3% to HK$34.3.
It hits an intra-day high of HK$34.3, and an intra-day low of HK$30.38. The total shares traded was 13.83 million, with a value of HK$453.69m. The active buy/sell ratio is 63:37, with net buying turnover of HK$119.04m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$5.56m, with volume weighted average price of HK$32.82. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$44.33m, with volume weighted average price of HK$32.85.
Basic Information| Nominal | 34.300 | % Chg | +10.29% |
| High | 34.300 | Low | 30.380 |
| Shares Tr | 13.83m | Turnover | 453.69m |
| 10-D SMA | 29.966 | %H.V | 152.880 |
| 20-D SMA | 28.014 | VWAP | 32.810 |
| 50-D SMA | 26.900 | RSI14 | 63.059 |
Status: Active buy/sell ratio is 63:37, with net buying turnover of HK$119.04m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| EVEREST MED (01952) | 34.30 | +10.29 |
| GENSCRIPT BIO (01548) | 34.86 | +6.87 |
| INNOVENT BIO (01801) | 100.50 | +1.00 |
| WUXI XDC (02268) | 78.45 | +12.39 |
| WUXI BIO (02269) | 50.40 | +3.70 |
| WUXI APPTEC (02359) | 199.80 | +1.06 |
| BEONE MEDICINES (06160) | 222.40 | +0.45 |
| ASYMCHEM (06821) | 124.60 | +12.15 |
| AKESO (09926) | 88.35 | Unchanged |
| REMEGEN (09995) | 78.80 | +6.20 |
(ed)
